PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

July 9th, 2009 Issue 37 Vol. 4
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Sanofi Gets Green Light on Blockbuster Heart Treatment
Sanofi-Aventis is banking that Multaq will be worth the wait
» MORE

Hidden Costs in Health Reform Deals
As the White House trumpets big agreements, what the industry groups will be getting in return is rarely discussed
» MORE

Caraco Pharma Eliminates 350 Jobs
Generics firm Caraco released more than half its employees, after FDA seized 30 of its products and shut down manufacturing
» MORE

Abbott Loses Patent Suit to J&J
Abbott Labs lost its battle against Johnson & Johnson as a federal jury levied $1.67 billion in damages for patent infringement
» MORE

Doctor by Choice, a Businessman by Necessity
A greater focus on money comes at a cost to the medical profession
» MORE

PharmRep Direct Features

Stealth Pharma
The third annual audit reveals how pharma's "other half" performs
» MORE

Elevated CRP Alone Doesn't Justify Statins
There does not appear to be a causal association between CRP and coronary heart disease according to Journal of the American Medical Association
» MORE

What's wrong with Massachusetts?

When a new state law created an estimated 432,000 newly insured residents in less than two years, Massachusetts' glut of doctors quickly became a shortage
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
How much do state regulations impact your ability to talk with doctors?
Click Here to Vote

PharmRep Direct Quick Links
Should You Worry About Acetaminophen?

WHO Not Worried Yet About Flu Pandemic

EU Probes Generic Delays

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!